Qingdao Sanbai Shuo Controlling Shareholder and Concerted Actor Complete Share Reduction; Cumulative Reduction of 7.225 Million Shares; Shareholding Ratio Decreased to 50.35%

Login to Sina Finance App and search for [Disclosure of Information] to see more evaluation levels

Qingdao Sanbai Shuo Health Technology Co., Ltd. (stock abbreviation: Sanbai Shuo, stock code: 001300) announced on March 17, 2026, that the company’s controlling shareholder, Qingdao Haishuo Health Industry Development Co., Ltd. (hereinafter referred to as “Haishuo Development”) and its concerted action partner, Ningbo Hechuang Financial Wisdom Investment Partnership (Limited Partnership) (hereinafter referred to as “Ningbo Hechuang”), have completed the previously disclosed share reduction plan. The total shares reduced amount to 7,224,955 shares, accounting for 2.9638% of the company’s total share capital. After the reduction, the shareholding ratio of the controlling shareholder and its concerted action partners decreased from 52.6130% to 50.3530%.

Details of the Share Reduction Plan Implementation

According to the announcement, Haishuo Development and its concerted action partner Ningbo Hechuang’s reduction plan was pre-disclosed on January 15, 2026. The plan was to reduce no more than 7,274,400 shares (2.9841% of the company’s total share capital) through centralized bidding and block trades within three months after the disclosure, starting 15 trading days after the disclosure date. As of March 16, 2026, the plan has been fully implemented, with actual share reductions not exceeding the planned maximum.

The specific reduction details are as follows:

From the reduction methods, the controlling shareholder and its concerted action partner mainly used centralized bidding and block trades. The bidding occurred from February 9 to March 2, 2026, with prices ranging from 17.16 to 17.43 yuan per share. The block trade was concentrated on March 16, 2026, at an average price of 15.20 yuan per share.

Shareholding Changes Before and After the Reduction

After the completion of the reduction, the shareholding structure of Haishuo Development and its concerted action partner Ningbo Hechuang changed significantly. Specifically:

Data shows that before the reduction, the controlling shareholder and its concerted action partner held a total of 128.26 million shares, accounting for 52.6130% of the total share capital. After the reduction, their combined holdings decreased to approximately 123.0 million shares, representing 50.3530%, remaining the largest shareholder of the company.

Impact on the Company and Future Arrangements

The announcement clearly states that the implementation of this reduction plan complies with the “Securities Law,” “Shenzhen Stock Exchange Stock Listing Rules,” and other relevant laws and regulations. The actual reduction did not exceed the pre-disclosed plan, and all necessary information disclosure obligations have been fulfilled. This equity change will not lead to a change in the company’s control or have a significant impact on corporate governance and ongoing operations.

Qingdao Sanbai Shuo stated that the company will continue to focus on its main business development. If the controlling shareholder and its concerted action partners have any further shareholding plans, they will strictly follow regulatory requirements and disclose information in a timely manner.

(Data source: Announcement of Qingdao Sanbai Shuo Health Technology Co., Ltd.)

Disclaimer: The market involves risks; investment should be cautious. This article is automatically published by an AI model based on third-party databases and does not represent Sina Finance’s views. All information herein is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. For questions, contact biz@staff.sina.com.cn.

Click to view the original announcement>>